ACS-15

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameACS-15
Drug Alias NameS-diclofenacsulfur-NSAIDs (CTG Pharma)H2S-releasing diclofenac (CTG Pharma)ACS-15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsInflammationArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCTG Pharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCTG Pharma Srl
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A